Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Herpes simplex Infection

  Free Subscription


Articles published in Antiviral Res

Retrieve available abstracts of 24 articles:
HTML format



Single Articles


    May 2021
  1. HARRISON KS, Jones C
    Wnt antagonists suppress herpes simplex virus type 1 productive infection.
    Antiviral Res. 2021 May 4:105082. doi: 10.1016/j.antiviral.2021.105082.
    PubMed     Abstract available


    March 2021
  2. LUGANINI A, Sibille G, Mognetti B, Sainas S, et al
    Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
    Antiviral Res. 2021 Mar 11:105057. doi: 10.1016/j.antiviral.2021.105057.
    PubMed     Abstract available


    February 2021
  3. ALVAREZ DM, Duarte LF, Corrales N, Smith PC, et al
    Corrigendum to "Cetylpyridinium chloride blocks herpes simplex virus replication in gingival fibroblasts" [Anti. Res. 179 (2020) 104818].
    Antiviral Res. 2021 Feb 22:105022. doi: 10.1016/j.antiviral.2021.105022.
    PubMed    


    August 2020
  4. LEVANOVA AA, Kalke KM, Lund LM, Sipari N, et al
    Enzymatically synthesized 2'-fluoro-modified Dicer-substrate siRNA swarms against herpes simplex virus demonstrate enhanced antiviral efficacy and low cytotoxicity.
    Antiviral Res. 2020 Aug 13:104916. doi: 10.1016/j.antiviral.2020.104916.
    PubMed     Abstract available


    May 2020
  5. ALVAREZ DM, Duarte LF, Corrales N, Smith PC, et al
    Cetylpyridinium chloride blocks herpes simplex virus replication in gingival fibroblasts.
    Antiviral Res. 2020;179:104818.
    PubMed     Abstract available


  6. IQBAL A, Suryawanshi R, Yadavalli T, Volety I, et al
    BX795 Demonstrates Potent Antiviral Benefits against Herpes Simplex Virus-1 Infection of Human Cell Lines.
    Antiviral Res. 2020 May 4:104814. doi: 10.1016/j.antiviral.2020.104814.
    PubMed     Abstract available


  7. KIM HC, Oh DS, Park JH, Kim HJ, et al
    Multivalent DNA vaccine protects against genital herpes by T-cell immune induction in vaginal mucosa.
    Antiviral Res. 2020;177:104755.
    PubMed     Abstract available


    March 2020
  8. LI W, Xu C, Hao C, Zhang Y, et al
    Inhibition of herpes simplex virus by myricetin through targeting viral gD protein and cellular EGFR/PI3K/Akt pathway.
    Antiviral Res. 2020 Mar 9:104714. doi: 10.1016/j.antiviral.2020.104714.
    PubMed     Abstract available


    February 2020
  9. GREELEY ZW, Giannasca NJ, Porter MJ, Margulies BJ, et al
    Acyclovir, cidofovir, and amenamevir have additive antiviral effects on herpes simplex virus TYPE 1.
    Antiviral Res. 2020;176:104754.
    PubMed     Abstract available


  10. SAMIES NL, James SH
    Prevention and treatment of neonatal herpes simplex virus infection.
    Antiviral Res. 2020 Feb 7:104721. doi: 10.1016/j.antiviral.2020.104721.
    PubMed     Abstract available


    October 2019
  11. VIEGAS DJ, Edwards TG, Bloom DC, Abreu PA, et al
    Virtual screening identified compounds that bind to cyclin dependent kinase 2 and prevent herpes simplex virus type 1 replication and reactivation in neurons.
    Antiviral Res. 2019 Oct 18:104621. doi: 10.1016/j.antiviral.2019.104621.
    PubMed     Abstract available


    May 2019
  12. MERCIER-DARTY M, Boutolleau D, Rodriguez C, Burrel S, et al
    Added value of ultra-deep sequencing (UDS) approach for detection of genotypic antiviral resistance of herpes simplex virus (HSV).
    Antiviral Res. 2019 May 31. pii: S0166-3542(19)30021.
    PubMed     Abstract available


    January 2019
  13. MAJMUDAR H, Hao M, Sankaranarayanan NV, Zanotti B, et al
    A synthetic glycosaminoglycan mimetic blocks HSV-1 infection in human iris stromal cells.
    Antiviral Res. 2019;161:154-162.
    PubMed     Abstract available


    October 2018
  14. LANGLAND J, Jacobs B, Wagner CE, Ruiz G, et al
    Antiviral activity of metal chelates of caffeic acid and similar compounds towards herpes simplex, VSV-Ebola pseudotyped and vaccinia viruses.
    Antiviral Res. 2018;160:143-150.
    PubMed     Abstract available


    February 2018
  15. BRUNNEMANN AK, Hoffmann A, Deinhardt-Emmer S, Nagel CH, et al
    Relevance of non-synonymous thymidine kinase mutations for antiviral resistance of recombinant herpes simplex virus type 2 strains.
    Antiviral Res. 2018 Feb 7. pii: S0166-3542(17)30749.
    PubMed     Abstract available


    January 2018
  16. CRISCUOLO E, Clementi N, Mancini N, Burioni R, et al
    Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle.
    Antiviral Res. 2018 Jan 18. pii: S0166-3542(17)30769.
    PubMed     Abstract available


    November 2017
  17. ZINSER E, Krawczyk A, Muhl-Zurbes P, Aufderhorst U, et al
    A new promising candidate to overcome drug resistant herpes simplex virus infections.
    Antiviral Res. 2017 Nov 15. pii: S0166-3542(17)30538.
    PubMed     Abstract available


  18. QUENELLE DC, Birkmann A, Goldner T, Pfaff T, et al
    Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis.
    Antiviral Res. 2017 Nov 4. pii: S0166-3542(17)30621.
    PubMed     Abstract available


    October 2017
  19. DU R, Wang L, Xu H, Wang Z, et al
    A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.
    Antiviral Res. 2017 Oct 20. pii: S0166-3542(17)30471.
    PubMed     Abstract available


    July 2017
  20. CLEMENTI N, Criscuolo E, Cappelletti F, Quaranta P, et al
    Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge.
    Antiviral Res. 2017;143:48-61.
    PubMed     Abstract available


    June 2017
  21. LI T, Liu L, Wu H, Chen S, et al
    Anti-herpes simplex virus type 1 activity of Houttuynoid A, a new flavonoid from Houttuynia cordata Thunb.
    Antiviral Res. 2017 Jun 16. pii: S0166-3542(17)30138.
    PubMed     Abstract available


  22. D'AIUTO L, Williamson K, Dimitrion P, McNulty J, et al
    Comparison of three cell-based drug screening platforms for HSV-1 infection.
    Antiviral Res. 2017;142:136-140.
    PubMed     Abstract available


    April 2017
  23. YOU H, Yuan H, Fu W, Su C, et al
    Herpes simplex virus type 1 abrogates the antiviral activity of Ch25h via its virion host shutoff protein.
    Antiviral Res. 2017 Apr 9. pii: S0166-3542(16)30777.
    PubMed     Abstract available


    March 2017
  24. YAJIMA M, Yamada H, Takemoto M, Daikoku T, et al
    Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor.
    Antiviral Res. 2017;139:95-101.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Herpes simplex Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: